ATS — ATS Corporation

ATS Corporation Q3 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Order Bookings: $821 million, up 12% sequentially but down 7% year-over-year due to lower run rates in Transportation and large enterprise bookings in previous year.
• Revenue: $761 million, a 17% increase from Q3 2025, driven by organic growth and a 4.1% benefit from foreign exchange.
• Adjusted Earnings from Operations: $80 million, reflecting a 21.6% increase year-over-year.
• Gross Margin: 29.6%, down 111 basis points from the previous year, attributed to program mix.
• Earnings per Share (EPS): $0.48 on an adjusted basis.
• Order Backlog: Approximately $2.1 billion, with a book-to-bill ratio of 1.06:1.

2. Strategic Updates and Business Highlights

• Leadership Changes: Doug Wright assumed the role of CEO in January 2026, emphasizing execution discipline, margin performance, and capital allocation.
• New Appointments: Sarah Moore appointed as Life Sciences Group Executive and Simon Roberts to lead Packaging & Food Technology.
• Service Integration: Services business embedded within operating units to enhance accountability and customer alignment.
• Recognition: ATS received accolades as a top employer in the U.S. and Waterloo area, reflecting strong organizational culture.

3. Forward Guidance and Outlook

• Q4 Revenue Guidance: Expected to range between $710 million and $750 million.
• Year-to-Date Performance: Revenue growth of 13.6% and adjusted earnings up 14%.
• Capital Expenditures: Expected to be between $70 million and $90 million for fiscal 2026, slightly lower than previous guidance.
• Focus Areas: Continued emphasis on margin expansion, operational efficiency, and strategic growth investments.

4. Challenges and Points of Concern

• Transportation Sector: Continued pressure with expected lower run rates; the segment is being approached with caution.
• Gross Margin Decline: Decrease attributed to program mix and timing of projects, indicating potential volatility in profitability.
• Restructuring Costs: Increased restructuring costs of $20 million expected, which may impact short-term financials.
• Macro Environment: Ongoing geopolitical and trade uncertainties, though no significant impact from tariffs noted.

5. Notable Q&A Insights

• CEO Priorities: Doug Wright highlighted a focus on core end markets, margin expansion opportunities, and disciplined capital allocation.
• Life Sciences Growth: Continued demand for GLP-1 auto-injectors and radiopharmaceuticals, with diversification in applications noted.
• Energy Sector: Strong backlog driven by refurbishment projects, with ongoing engagement in new build programs.
• Transportation Strategy: Emphasis on targeted opportunities within the EV sector, avoiding large-scale projects due to associated risks.
• Capital Allocation: Future M&A activity is anticipated as leverage ratios improve, with a commitment to disciplined investment strategies.

Overall, ATS demonstrated solid financial performance in Q3 2026, with strategic initiatives aimed at enhancing operational efficiency and market positioning, despite facing challenges in the Transportation sector and margin pressures.